SLC9C1 and osteosarcoma: This is supported by evidence collected during in vitro preliminary studies performed by the authors which showed cellular death was increased in a dose dependent manner using the PPI omeprazole and the NHE blocker amiloride in canine osteosarcoma cells (Fig. 3a).